(#, co-first author with, * , corresponding author)

1. Fan Y#, Gao Y#, Nie L#, Hou T, Dan W, Wang Z, Liu T, Wei Y, Wang Y, Liu B, Que T, Lei Y, Zeng J, Ma J, Wei W*, Li L*. Targeting LYPLAL1-mediated cGAS depalmitoylation enhances the response to anti-tumor immunotherapy. Molecular Cell. 2023, 83(19):3520-3532.e7.
2. Dai X^#, Bu X^#, Gao Y^#, Guo J, Hu J, Jiang C, Zhang Z, Xu K, Duan J, He S, Zhang J, Wan L, Liu T, Zhou X, Hung MC, Freeman GJ*, Wei W*. Energy status dictates PD-L1 protein abundance and anti-tumor immunity to enable checkpoint blockade. Molecular Cell. 2021, 81(11): 2317-2331.
3. Gao Y^#, Nihira NT^#, Bu X^#, Chu C, Zhang J, Kolodziejczyk A, Fan Y, Chan NT, Ma L, Liu J, Wang D, Dai X, Liu H, Ono M, Nakanishi A, Inuzuka H, North BJ, Huang YH, Sharma S, Geng Y, Xu W, Liu XS, Li L, Miki Y, Sicinski P*, Freeman GJ*, Wei W*. Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy. Nature Cell Biology. 2020, 22(9): 1064-1075.
4. Xiong W^#, Gao Y^#, Wei W*, Zhang J*. Extracellular and nuclear PD-L1 in modulating cancer immunotherapy. Trends in Cancer. 2021, 7(9): 837-846.
5. Dai X^#, Gao Y^#, Wei W*. Post-translational regulations of PD-L1/PD-1: Mechanisms and opportunities for combined immunotherapy. Seminars in Cancer Biology. 2021, S1044-579X(21)00103-6.
6. Fan Y^#, Hou T^#, Gao Y^#, Dan W, Liu T, Liu B, Chen Y, Xie H, Yang Z, Chen J, Zeng J*, Li L*. Acetylation-dependent regulation of TPD52 isoform 1 modulates chaperone-mediated autophagy in prostate cancer. Autophagy. 2021: 1-15.